We have collected information about Designing Dendrimers Ocular Drug Delivery for you. Follow the links to find out details on Designing Dendrimers Ocular Drug Delivery.
https://www.sciencedirect.com/science/article/pii/S0223523409005194
Designing dendrimers for ocular drug delivery. ... However, most of these studies concern in vitro delivery, and only very few in vivo drug delivery studies using dendrimers are available to date . The first important point to be verified for such purpose concerns the water solubility and the biocompatibility .Author: Grégory Spataro, Grégory Spataro, François Malecaze, Cédric-Olivier Turrin, Cédric-Olivier Turrin, V...
https://kundoc.com/pdf-designing-dendrimers-for-ocular-drug-delivery-.html
Designing dendrimers for ocular drug delivery Gre´gory Spataro a, b, François Malecaze c, **, Ce´dric-Olivier Turrin a, b, Vincent Soler c, Carine Duhayon a, b, Pierre-Paul Elena d, **, Jean-Pierre Majoral a, b, **, Anne-Marie Caminade a, b, * a
https://www.researchgate.net/publication/38067224_Designing_dendrimers_for_ocular_drug_delivery
Designing dendrimers for ocular drug delivery Article in European Journal of Medicinal Chemistry 45(1):326-34 · October 2009 with 51 Reads How we measure 'reads'
https://www.sciencedirect.com/science/article/abs/pii/S0223523409005194
The solubility in water of these charged dendrimers depends on the generation considered: generation 0 (3 carteolol) is well soluble, whereas generation 1 (6 carteolol) and generation 2 (12 carteolol) are poorly soluble. These dendrimers have been tested in vivo, as vehicle for …
https://www.researchgate.net/publication/317140606_Dendrimers_for_Ocular_Drug_Delivery
Dendrimers are tree-like, nanostructured polymers that have received significant attention as ocular drug delivery systems, due to their well-defined size, tailorable structure, and potentially ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694674/
The ideal ocular drug delivery system should be nonirritating, isotonic, biocompatible, and biodegradable. It should also prolong the release of the drug, reduce side effects, and target the desirable eye segment. Investigations of targeted drug–dendrimers for their use in different ocular diseases are discussed ahead.Author: Marina Kalomiraki, Kyriaki Thermos, Nikos A Chaniotakis
Searching for Designing Dendrimers Ocular Drug Delivery?
You can just click the links above. The data is collected for you.
